MACROBIAN-BIOTECH
Macrobian-Biotech aims at performing clinical research and treatments for disorders affecting the dopamine system.
MACROBIAN-BIOTECH
Social Links:
Industry:
Biotechnology Clinical Trials Neuroscience
Founded:
2017-01-01
Address:
Amsterdam, Noord-Holland, The Netherlands
Country:
The Netherlands
Website Url:
http://www.macrobian-biotech.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
OVH Instra
Similar Organizations
Balter Medical
Balter Medical is an optical imaging company that develops devices to aid tissue diagnostics.
Fondazione Neurone Onlus
Fondazione Neurone Onlus offers financial support in study and research for treating neurological and psychiatric diseases.
Official Site Inspections
http://www.macrobian-biotech.com
Unable to get host informations!!!

More informations about "Macrobian-Biotech"
Macrobian Biotech - LinkedIn
Macrobian Biotech | 209 followers on LinkedIn. Towards Novel Treatments for Parkinson's Disease | Macrobian Biotech was founded in May 2017 by Dr. Lars van der Heide and Prof. dr. โฆSee details»
New directors of Amsterdam Neuroscience
Macrobian Biotech - PitchBook
Information on valuation, funding, cap tables, investors, and executives for Macrobian Biotech. Use the PitchBook Platform to explore the full profile.See details»
Macrobian Biotech BV - Crunchbase Company Profile & Funding
Where is Macrobian Biotech BV 's headquarters? Macrobian Biotech BV is located in Amsterdam, Noord-Holland, The Netherlands. Who invested in Macrobian Biotech BV? Macrobian Biotech โฆSee details»
Macrobian-Biotech - Crunchbase Company Profile & Funding
Macrobian-Biotech aims at performing clinical research and treatments for disorders affecting the dopamine system.See details»
Biotechnology at Amsterdam Science Park
Macrobian Biotech is leading the way in new treatments for disorders of the dopamine system, including Parkinsonโs disease. The UvA biocatalysis group works at the intersection of โฆSee details»
New directors of Amsterdam Neuroscience - SILS
Feb 8, 2022ย ยท Smidt is the founder and CEO of Macrobian Biotech, a spin-off company that develops novel medication to treat and stop Parkinsonโs disease progression. As co-director of Amsterdam Neuroscience Smidt will draw โฆSee details»
Marten Smidt - Amsterdam UMC
It is the ambition of Macrobian-Biotech to be at the forefront of clinical trial ready compound development vivifying novel treatments of neurological and neuropsychiatric diseases. please โฆSee details»
Macrobian Biotech BV - VentureRadar
"Macrobian-Biotech was founded in May 2017 by Dr. Lars van der Heide and Prof. dr. Marten Smidt. Its primary goal is to perform pre-clinical research that leads to noval treatments for โฆSee details»
Macrobian-Biotech - Products, Competitors, Financials, Employees ...
Macrobian-Biotech focuses on developing novel treatments for Parkinson's disease within the biotechnology sector. The company's main offerings include innovative solutions that enhance โฆSee details»
Amsterdam Science Park spotlight: UvA-Macrobian-Biotech โฆ
Science & Business interviews Marten Smidt, CEO of Macrobian Biotech about the development of revolutionary Parkinson's drugs. Read the full interview here.See details»
Macrobian-Biotech - Crunchbase
Macrobian-Biotech aims at performing clinical research and treatments for disorders affecting the dopamine system.See details»
UvA spin-off Macrobian Biotech secures seed investment
Jun 13, 2024ย ยท The University of Amsterdam (UvA)โs Faculty of Science, UvA Ventures Holding B.V. and Innovation Exchange Amsterdam (IXA-UvA) are pooling their resources to fund โฆSee details»
Macrobian Biotech BV | VentureRadar
Macrobian-Biotech was founded in May 2017 by Dr. Lars van der Heide and Prof. dr. Marten Smidt. Its primary goal is to perform pre-clinical research that leads to noval treatments for โฆSee details»
Macrobian Biotech BV - Drug pipelines, Patents, Clinical trials
Explore Macrobian Biotech BV with its drug pipeline, therapeutic area, technology platform, 1 literature.See details»
Macrobian Biotech BV - VentureRadar
Macrobian-Biotech was founded in May 2017 by Dr. Lars van der Heide and Prof. dr. Marten Smidt. Its primary goal is to perform pre-clinical research that leads to noval treatments for โฆSee details»
Macrobian-Biotech - Tech Stack, Apps, Patents & Trademarks
Macrobian-Biotech aims at performing clinical research and treatments for disorders affecting the dopamine system.See details»
Macrobian Biotech BV - Funding, Financials, Valuation & Investors
May 15, 2017ย ยท Macrobian Biotech BV has raised 2 rounds. Their latest funding was raised on May 15, 2017 from a Pre-Seed round. Macrobian Biotech BV is funded by 2 investors. UvA โฆSee details»